BioCentury | Jan 17, 2005
Clinical News

FASgen preclinical data

In a mouse model of TB, FAS20013 was shown to be effective and gave no adverse side effects. The compound is 100% orally bioavailable. No dose limiting toxicity was observed even at doses 10 times...
Items per page:
1 - 1 of 1